PCDH17 anticorps (C-Term)
Aperçu rapide pour PCDH17 anticorps (C-Term) (ABIN631153)
Antigène
Voir toutes PCDH17 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- PCDH17 antibody was raised against the C terminal of PCDH17
-
Purification
- Affinity purified
-
Immunogène
- PCDH17 antibody was raised using the C terminal of PCDH17 corresponding to a region with amino acids SEMGAVLEQLDHPNRDLGRESVDAEEVVREIDKLLQDCRGNDPVAVRK
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
PCDH17 Blocking Peptide, (ABIN5615243), is also available for use as a blocking control in assays to test for specificity of this PCDH17 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of PCDH17 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- PCDH17 (Protocadherin 17 (PCDH17))
-
Autre désignation
- PCDH17
-
Sujet
- PCDH17 contains six extracellular cadherin domains, a transmembrane domain, and a cytoplasmic tail differing from those of the classical cadherins.It may play a role in the establishment and function of specific cell-cell connections in the brain.
-
Poids moléculaire
- 124 kDa (MW of target protein)
Antigène
-